Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Valley National Bancorp Common Stock (VLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Valley National Bancorp Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while Valley National Bancorp Common Stock trades at $12.64 (market cap $6.90B). The key difference: Valley National Bancorp Common Stock is far larger — about 3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Valley National Bancorp Common Stock pays a 3.53% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | VLY | |
|---|---|---|
Market Cap | $2.28B | $6.90B |
Volume | 3,128,960 | 8,032,586 |
Sector | Health | Financials |
52-Week High | $15.46 | $15.19 |
52-Week Low | $1.39 | $9.72 |
Enterprise Value | $2.15B | $9.40B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 3.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Valley National Bancorp Common Stock
Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →
